Northwestern Mutual Wealth Management CO Zynerba Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$0.5 - $0.72 $125 - $180	-250 Reduced 98.81%	3 $0
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $217 - $340	250 Added 8333.33%	253 $0
Q1 2022 May 09, 2022	BUY	$1.83 - $3.02 $5 - $9	3 New	3 $0

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.